APA (7th ed.) Citation

Vráblová, L., Klamová, H., Skoumalová, I., Navrátilová, J., Janská, R., Grohmann, J., . . . Faber, E. Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression. Elsevier.

Chicago Style (17th ed.) Citation

Vráblová, Lucia, Hana Klamová, Ivana Skoumalová, Jana Navrátilová, Romana Janská, Jan Grohmann, Milena Holzerová, and Edgar Faber. Treatment with Low-dose Tyrosine Kinase Inhibitors Due to Significant Haematologic Toxicity in Patients with CML with Prolonged Treatment Failure Prevents Haematologic Progression. Elsevier.

MLA (9th ed.) Citation

Vráblová, Lucia, et al. Treatment with Low-dose Tyrosine Kinase Inhibitors Due to Significant Haematologic Toxicity in Patients with CML with Prolonged Treatment Failure Prevents Haematologic Progression. Elsevier.